|
Market Closed -
Nasdaq
16:00:00 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 56.60 USD | -0.35% |
|
+2.39% | +16.75% |
| 07-13 | GSK posts encouraging data for bowel cancer treatment Jemperli | AN |
| 06-29 | AnaptysBio, Inc.(NasdaqGS:ANAB) dropped from Russell 3000E Growth Benchmark | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ANAB | Delayed | |
CBOE
| ANAB | Real-time | |
|
Boerse Muenchen
| AN6 | Real-time | |
|
Deutsche Boerse AG
| AN6 | Delayed | |
|
Tradegate
| AN6 | Real-time | |
|
Börse Stuttgart
| AN6 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bullish |
| Resistance | 59.69 | 70.22 | 70.1 |
| Spread/Res. | -5.18% | -19.40% | -19.26% |
| Spread/Supp. | +8.62% | +12.55% | +12.97% |
| Support | 52.11 | 50.29 | 50.1 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ANAB Stock
- Charts AnaptysBio, Inc.
Select your edition
All financial news and data tailored to specific country editions
